NEWS

Stem Cell Clinics Pitch Pricey, Bogus ‘Cures’ for Knee Pain – U.S. News & World Report

2018-03-07 Michael Zand NEWS

UPDATE: CRISPR Therapeutics (CRSP) PT Raised to $59 at Barclays, Street High – StreetInsider.com

The Ledger GazetteUPDATE: CRISPR Therapeutics (CRSP) PT Raised to $59 at Barclays, Street HighStreetInsider.comBarclays raised its price target on CRISPR Therapeutics (NASDAQ: CRSP) to $59.00 (from $29.00) while maintaining a Overweight rating. Analyst… Continue reading

2018-03-07 Michael Zand NEWS

Consensus recommendations aim to align management of immunotherapy side effects – Healio

Consensus recommendations aim to align management of immunotherapy side effectsHealioThe Society for Immunotherapy of Cancer released the first set of consensus recommendations on the diagnosis and management of immune checkpoint inhibitor-related adve… Continue reading

2018-03-07 Michael Zand NEWS

Ultragenyx says three patients in phase 1/2 gene therapy study had positive results – MarketWatch

EconoTimesUltragenyx says three patients in phase 1/2 gene therapy study had positive resultsMarketWatchUltragenyx Pharmaceutical Inc. RARE, +0.95% shares rose 2.5% in premarket trade Wednesday after the company said that the first dose cohort of three… Continue reading

2018-03-07 Michael Zand NEWS

Intricate Supply Chain Complicates Gene Therapy Manufacturing – Life Science Leader Magazine

Intricate Supply Chain Complicates Gene Therapy ManufacturingLife Science Leader MagazineAfter three decades of disappointments and clinical setbacks, gene therapy is finally delivering on its promise to alleviate – and possibly even cure – a long list… Continue reading

2018-03-07 Michael Zand NEWS

Global Gene Therapy Market Analysis & Forecast to 2022: $350+ Million Market Strengthened by Recent Approvals of … – GlobeNewswire (press release)

Global Gene Therapy Market Analysis & Forecast to 2022: $350+ Million Market Strengthened by Recent Approvals of …GlobeNewswire (press release)Strengthened by recent approvals of Kymriah, Yescarta and Luxturna in the US, and a committed European,… Continue reading

2018-03-07 Michael Zand NEWS

STEMCELL Technologies Signs Exclusive License with IU Innovation and Commercialization Office for Inner Ear … – Business Wire (press release)

Business Wire (press release)STEMCELL Technologies Signs Exclusive License with IU Innovation and Commercialization Office for Inner Ear …Business Wire (press release)The inner ear contains organs responsible for detecting sounds and maintaining bala… Continue reading

2018-03-07 Michael Zand NEWS

1
…
431
432
433
434
435
…
3,595

Stem Cell Clinics Pitch Pricey, Bogus ‘Cures’ for Knee Pain
U.S. News & World Report
WEDNESDAY, March 7, 2018 (HealthDay News) — Stem cell clinics are charging big money for knee arthritis “cures” and making extravagant claims about their therapies, a new study contends. A same-day injection for one knee costs thousands of dollars at …

and more »

Login

Cart

Expert Highlights Advancements in MCL and Other Lymphomas – Targeted Oncology

Stem Cell Clinics Pitch Pricey, Bogus ‘Cures’ for Knee Pain – U.S. News & World Report

UPDATE: CRISPR Therapeutics (CRSP) PT Raised to $59 at Barclays, Street High – StreetInsider.com

Consensus recommendations aim to align management of immunotherapy side effects – Healio

Ultragenyx says three patients in phase 1/2 gene therapy study had positive results – MarketWatch

Intricate Supply Chain Complicates Gene Therapy Manufacturing – Life Science Leader Magazine

Global Gene Therapy Market Analysis & Forecast to 2022: $350+ Million Market Strengthened by Recent Approvals of … – GlobeNewswire (press release)

STEMCELL Technologies Signs Exclusive License with IU Innovation and Commercialization Office for Inner Ear … – Business Wire (press release)

Recent Posts

Blog Categories

Blog Categories

Blog Categories

Blog Categories

Blog Categories